These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9190574)

  • 21. The requirement of yeast Ssl2 (Rad25) for the repair of cisplatin-damaged DNA.
    Yang WL; Cvijic ME; Ishii K; Chin KV
    Biochem Biophys Res Commun; 1998 Sep; 250(3):593-7. PubMed ID: 9784390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low renal toxicity of lipoplatin compared to cisplatin in animals.
    Devarajan P; Tarabishi R; Mishra J; Ma Q; Kourvetaris A; Vougiouka M; Boulikas T
    Anticancer Res; 2004; 24(4):2193-200. PubMed ID: 15330160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
    Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
    Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of cisplatin and its conjugate with glutathione on blood platelet activity.
    Olas B; Wachowicz B
    Platelets; 1998; 9(1):69-72. PubMed ID: 16793748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite.
    Zhang J; Peng D; Lu H; Liu Q
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):251-9. PubMed ID: 17950769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity.
    Li J; Sun K; Ni L; Wang X; Wang D; Zhang J
    Toxicol Appl Pharmacol; 2012 Feb; 258(3):376-83. PubMed ID: 22172630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of cis-diamminedichloroplatinum, selenite and a conjugate of cisplatin with selenite [(NH3)2Pt(SeO3)] on oxidative stress in blood platelets measured by chemiluminescence method.
    Olas B; Zbikowska HM; Wachowicz B; Buczyński A; Krajewski T
    J Physiol Pharmacol; 1999 Jun; 50(2):299-308. PubMed ID: 10424724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
    Tikoo K; Ali IY; Gupta J; Gupta C
    Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats.
    el Daly ES
    J Pharm Belg; 1998; 53(2):87-93; discussion 93-5. PubMed ID: 9609969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system.
    Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK
    Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
    Callizot N; Andriambeloson E; Glass J; Revel M; Ferro P; Cirillo R; Vitte PA; Dreano M
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):995-1007. PubMed ID: 18270703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
    Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
    Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK; Kwon YE
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
    Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
    Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
    Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA; Budihardjo II; Rowinsky EK; Kottke TJ; Svingen PA; Buckwalter CA; Grochow LB; Donehower RC; Kaufmann SH
    Clin Cancer Res; 1997 May; 3(5):761-70. PubMed ID: 9815747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.